The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 15, 2022

Filed:

May. 04, 2018
Applicant:

Prodeon, Inc., Taipei, TW;

Inventors:

Mark Huang, Pleasanton, CA (US);

Kenneth Chih-Ping Chang, San Jose, CA (US);

Jimmy Jen, Saratoga, CA (US);

Yue-Teh Jang, Los Altos, CA (US);

Thomas Hsu, Foster City, CA (US);

Senzan Hsu, Foster City, CA (US);

Kondapavulur T. Venkateswara-Rao, San Jose, CA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/04 (2013.01); A61F 2/90 (2013.01); A61B 17/00 (2006.01); A61B 17/3207 (2006.01); A61F 2/962 (2013.01); A61F 2/86 (2013.01); A61M 27/00 (2006.01); A61B 17/3209 (2006.01); A61F 2/95 (2013.01);
U.S. Cl.
CPC ...
A61F 2/90 (2013.01); A61B 17/00234 (2013.01); A61B 17/320725 (2013.01); A61F 2/04 (2013.01); A61F 2/86 (2013.01); A61F 2/962 (2013.01); A61B 17/3209 (2013.01); A61B 2017/00274 (2013.01); A61B 2017/32096 (2013.01); A61F 2002/047 (2013.01); A61F 2002/9528 (2013.01); A61F 2220/0008 (2013.01); A61F 2230/001 (2013.01); A61F 2230/0073 (2013.01); A61M 27/008 (2013.01);
Abstract

The invention is devices and methods to treat benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms infections (LUTS). The devices are intra-urethral implants placed in a patient in need thereof by minimally invasive procedures, preferably under local anesthesia in an office environment. The devices are sized and designed for atraumatic insertion and expansion within the urethra to engage and retract enlarged prostatic tissue proximate to the urethra that is leading to adverse symptoms associated with BPH. The methods include steps to deploy the implant devices of the invention using a delivery system of the invention and at target prostatic tissue that is visualized during the procedure and yields a reduction in the symptoms of BPH.


Find Patent Forward Citations

Loading…